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Diminishing returns and tradeoffs constrain
the laboratory optimization of an enzyme
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Optimization processes, such as evolution, are constrained by diminishing returns—the closer
the optimum, the smaller the benefit per mutation, and by tradeoffs—improvement of one
property at the cost of others. However, the magnitude and molecular basis of these para-
meters, and their effect on evolutionary transitions, remain unknown. Here we pursue a
complete functional transition of an enzyme with a 4109-fold change in the enzyme’s
selectivity using laboratory evolution. We observed strong diminishing returns, with the initial
mutations conferring 425-fold higher improvements than later ones, and asymmetric tra-
deoffs whereby the gain/loss ratio of the new/old activity decreased 400-fold from the
beginning of the trajectory to its end. We describe the molecular basis for these phenomena
and suggest they have an important role in shaping natural proteins. These findings also
suggest that the catalytic efficiency and specificity of many natural enzymes may be far from
their optimum.
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O
ptimization processes, be they industrial, economical,
computational or biological (evolutionary), share several
common features. Graduality: each step provides an
incremental improvement. Diminishing returns: the first steps
yield larger improvements than the later steps1,2, meaning that
the closer the process is to its optimum, the slower and less cost-
effective optimization becomes. Tradeoffs: the improvement of
the trait under optimization comes at the expense of other traits.
These aspects of evolutionary optimization have been
addressed3,4, yet our understanding of the processes that define
evolutionary optimization is by no means complete. For instance,
it has been shown that the first mutations have the largest impact,
and diminishing returns have been observed with respect to
metabolic pathways5, bacterial evolution6, population sizes7,
mutation rates8 and the evolution of antibiotic resistance9.
Similarly, functional tradeoffs have been studied in the context
of protein evolution3,10–12, yet previous works have focused on
the early steps of optimization. However, exactly how diminishing
returns and tradeoffs affect a complete evolutionary trajectory
involving the emergence of a new catalytic activity remains
unknown. Our understanding of the molecular basis for
diminishing returns and tradeoffs is also limited. Finally, the
potential implications of diminishing returns and tradeoffs on the
existing repertoire of biomolecules, and of enzymes in particular,
also remain unidentified.
Overall, data and insights regarding complete functional
transitions in enzymes are scarce. The starting points of natural
enzymes remain mostly unknown. In addition, there is no
way to reproduce the series of evolutionary intermediates that
underlie the divergence of natural enzymes. Laboratory
evolution (also dubbed experimental or directed evolution) can
allow us to characterize every intermediate in a trajectory and
thereby help us to understand the mechanisms and driving
forces of evolution13–15. Such experiments have shown how
new functional traits evolve, that is, by mutations increasing a
latent, weak, promiscuous activity11,16–19. Marked switches in
enzymatic functions have been achieved via laboratory evolution,
whereby the catalytic efficiency of the newly evolved enzyme
matched that of the starting point20. Although these experiments
provided novel insight, they involved both random and rational
(targeted) mutagenesis and/or varying substrates along the
trajectory21.
Here, we describe a complete evolutionary trajectory compris-
ing a functional transition from a naturally occurring phospho-
triesterase (PTE) from Pseudomonas diminuta that catalyses
the hydrolysis of the pesticide paraoxon with high efficiency
(kcat/KM¼ 2.2 107 M 1 s 1)22,23, to an arylesterase that
catalyses the hydrolysis of 2-naphthyl hexanoate (2NH; Fig. 1).
Although the original (PTE) and new (arylesterase) enzymes
catalyse hydrolysis, the reactions differ in the bond that is
hydrolysed (P–O versus C–O), the shape and binding orientation
of the substrates, and the geometry of the substrates (tetrahedral
versus planar) and transition states (TSs) (pentavalent versus
tetrahedral; Fig. 1). The laboratory evolution began from the
weak, promiscuous, arylesterase activity of wild-type PTE
(kcat/KM with 2NH¼ 4.2 102 M 1 s 1). Iterations of random
mutagenesis and selection for variants exhibiting higher
arylesterase rates led to the gradual fixation of 18 substitutions,
and a highly efficient arylesterase (kcat/KM¼ 1.7 107 M 1 s 1).
We isolated and characterized the intermediates of this
process, and could thus describe the entire trajectory. By
producing and characterizing this evolutionary trajectory, we
provide a quantitative description of the magnitude of
diminishing returns and tradeoffs throughout this trajectory,
and also describe the molecular basis of diminishing returns and
tradeoffs.
Results
Directed evolution of an arylesterase. The early steps of
PTE’s evolution into an arylesterase have been described
previously24–26. A PTE variant with higher expression in
Escherichia coli, dubbed PTE-S5, was previously evolved via
random mutagenesis and screening with 2-naphthyl acetate24.
PTE-S5 carried three mutations (Lys185Arg, Asp208Gly and
Arg319Ser) compared with the wild-type PTE. These mutations
improved the levels of soluble and functional enzyme in E. coli
but did not modify PTE’s enzymatic activities24. The variant that
served as our starting point for this trajectory (PTE-R0) possessed
four additional substitutions compared with PTE-S5 (including
two substitutions in the active site: Ile106Leu and Phe132Leu).
PTE-R0 exhibited 1.7-fold higher arylesterase activity than wild-
type PTE and PTE-S5, and 1.6-fold lower paraoxonase activity
(Supplementary Table S1). By virtue of its much higher
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Figure 1 | Structures of substrates. PTE’s native substrate, paraoxon
(a phosphotriester pesticide), and the promiscuous arylester 2NH that
comprised the evolutionary target.
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Figure 2 | The divergence of an arylesterase from an existing phosphotriesterase. (a) The observed gain in the evolved arylesterase activity with 2NH
and the loss of the original PTE activity. The enzymatic activity in crude cell lysates is plotted. (b) kcat/KM values measured with purified enzyme variants
(sequences and kinetic parameters are provided in Tables 2,3). (c) A tradeoff plot of the arylesterase (2NH) versus the original, paraoxonase activity.
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expression levels and of its slightly higher arylesterase activity,
PTE-R0 could serve as a starting point for our trajectory, because
in contrast to wild-type PTE, it showed a detectable level of 2NH
activity in the cell lysates.
PTE-R0 was subjected to random mutagenesis and screening
with 2NH to identify variants with enhanced arylesterase
activity. Mutagenesis was performed in vitro by error-prone
PCR. The resulting library (B104 transformants) was plated on
agar and screened for 2NH hydrolysis using the FAST Red
indicator that reacts with the released 2-naphthol product. Active
colonies were subsequently grown, lysed and tested for enzymatic
activity in 96-well plates. Variants that showed detectable
improvements relative to the best variant from the previous
round (Z1.3-fold) were isolated and used as the template for the
next round of mutagenesis and screening. In rounds where
multiple variants were isolated, DNA shuffling was performed to
recombine beneficial mutations (Table 1). The acquisition of the
arylesterase activity was facilitated by chaperonin overexpression,
as described previously26. At later stages, chaperonin
coexpression was suppressed and growth temperature restored
to 37 1C to promote the accumulation of compensatory,
stabilizing mutations (rounds 3 and 10–12; Table 1).
The first 14 rounds of mutagenesis and screening showed
detectable and reproducible improvements in the rate of 2NH
hydrolysis, as measured in crude cell lysates (Fig. 2a). By the
fifteenth round, however, the improvement plateaued. At this
stage, a high fraction of the library variants exhibited high
activity, but none appeared better than the starting point (41.3-
fold 2NH activity compared with R14). We therefore relaxed the
selection pressure, and during the fifteenth round, 190 of the
screened variants that showed Z30% activity of the starting point
(the best R14 variant) were subjected to gene shuffling (Table 1).
However, no improved variants were found in this library. The
sixteenth and seventeenth rounds behaved similarly. By the
eighteenth round, the best variants showed only twofold higher
2NH hydrolysis rates than the best R14 variant, although they
carried four additional mutations (Table 2 and Fig. 2a). Thus, the
weaker selection pressure (taking variants with lower activity than
the starting point) enabled us to accumulate neutral and slightly
advantageous mutations that ultimately led to detectable, albeit
small improvements.
A gradual functional transition with strong diminishing
returns. Over 18 rounds, the evolving arylesterase activity
increased gradually and smoothly, as indicated by the activity in
crude cell lysates (Fig. 2a). This was also our screening parameter,
reflecting both the specific activity (activity per enzyme molecule)
and amount of folded, active enzyme. The kinetic parameters
measured with purified variants indicated a parallel increase in
the arylesterase activity (kcat/KM increase of 3.3 104-fold;
Table 3 and Fig. 2b). The improvement in the arylesterase activity
occurred gradually, and was characterized by strong diminishing
returns. The early steps involved marked improvements: B1,100-
fold in the first four rounds, via four substitutions. Over the
subsequent five rounds (until R9), the activity increased by
another sevenfold via five substitutions. In the last rounds (R10–
R18), nine more substitutions only gave a 4.4-fold higher rate.
Over the entire trajectory, we observed a 425-fold decline in the
return per mutation: from an increase by B4.8-fold per sub-
stitution in the first four rounds, down to B0.18-fold in the last
eight rounds.
Asymmetric tradeoffs between the original and new activity.
The PTE activity was also monitored but was neither selected for
nor against. Many directed evolution experiments have demon-
strated that large improvements in the newly evolving function
were achieved with much smaller decreases in the original
function, thus resulting in bi-functional enzymes11. In our
evolutionary experiment, however, this trend was only apparent
over the first part of the trajectory. Overall, the increase in
arylesterase activity was accompanied by a 4 104-fold decrease
in the kcat/KM for paraoxon, amounting to a 109-fold change
between the two catalytic specificities. Unlike the smooth gain in
the arylesterase activity, the loss of the PTE activity was rugged
(Table 3 and Fig. 2a). The tradeoff between the new, evolving,
arylesterase and the original PTE activities was weak at the first
Table 1 | Summary of experimental conditions in each round of the evolution
Selection round Promoter* GroEL/ESw Mutagenesisz Tempy (1C) 2NH conc8 (lM) Note
R1 tac — epPCR 30 2NA 500z Ref. 25
R2 T7-wt GroEL/ES epPCR 30 100 Ref. 26
R3 T7-wt — epPCR 30 100 Ref. 26
R4 T7-wt — Shuffling 30 100 Best 6 clones from R2 and R3
R5 T7-wt GroEL/ES epPCR 30 100
R6 T7-2 GroEL/ES Shuffling 30 100 Best 7 clones from R6
R7 T7-2 GroEL/ES epPCR 30 100
R8 T7-2 GroEL/ES Shuffling 30 100 Best 5 clones from R6 and R7
R9 T7-2 GroEL/ES epPCR 37 100
R10 T7-wt — epPCR 37 100
R11 T7-wt — epPCR 37 100
R12 T7-wt — Shuffling 37 100 Best 10 clones from R11
R13 T7-4 GroEL/ES epPCR 30 20
R14 T7-4 GroEL/ES Shuffling 30 20 Best 5 clones from R13
R15 T7-4 GroEL/ES epPCR 30 20
R16 T7-4 GroEL/ES Shuffling 30 20 Best 200 clones of R15 (430% of G14)
R17 T7-4 GroEL/ES epPCR 30 20 Best 100 clones of R16
R18 T7-4 GroEL/ES Shuffling 30 20 Best 30 clones of R17
Ep, error-prone; wt, wild type; 2NH, 2-naphthyl hexanoate; 2NA, 2-naphthyl acetate.
*Different strengths of promoter were used to adjust to the dynamic range of the agar plate screening. T7 wt is the native T7 promoter sequence. T7-2 contains two mutations (A-6T and A-16C) resulting
in about 50 times lower expression. T7-4 contains four mutations (A-6T, T-8A, A-10T and A-16C), resulting in about 1,000 times lower expression.
wGroEL/ES overexpression was switched on or off depending on the soluble expression level of a parent variant.
zThe ep PCR was employed to create mutagenized library. When more than one variant was selected in the previous round, DNA shuffling was used to recombine beneficial mutations.
yThe growth temperature for the E. coli cells in the screening was changed to 37 1C, combined with GroEL/ES overexpression, to increase selection pressure to identify stabilizing mutations.
8The substrate concentration in the screening was changed from 100 to 20mM to increase the selection pressure and thereby decrease the KM value.
zThe first screen was performed with 2NA, due to the initially too low activity of the starting PTE variant with 2NH.
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stages as reported previously10,11, but far stronger at the later
stages. Thus, the tradeoff between the evolving esterase and the
original PTE activities followed a convex pattern with R6 being
the point where the rate at which the original activity was lost
overtook the rate at which the new activity was gained (Fig. 2c).
By round 6, a 1,600-fold gain in the arylesterase activity traded off
with a 28-fold loss in the PTE activity (57:1 gain:loss ratio).
Following round 6, this trend reversed and an overall 20-fold gain
in the arylesterase activity was accompanied by a B1,400-fold
loss of PTE activity (1:7 gain:loss ratio), amounting to a 400-fold
reversal in the tradeoff from the first to the second half of the
trajectory. Strong diminishing returns were therefore not only
seen in the improvement of the new activity, but also in the level
of tradeoff with the original activity. These results indicate that
the specialization of enzyme function can be shaped under
selection for one catalytic activity, and without negative selection
against the original20. Specialization, however, only occurred
during the later rounds, was accompanied by relatively small
Table 2 | The mutations of variants.
Enzyme Round Mutations*
H254R D233E F306 I274S T172I S269T M138I T199I L272M A80V S111R A204G L130V L271F A49V K77E L140M I313F
R0 0
R1 1 þ
R2a 2 þ F306I
R2b 2 þ þ
R3 3 þ F306I þ
R4 4 þ þ F306I þ
R5a 5 þ þ F306I þ þ
R5b 5 þ þ F306I þ þ
R6 6 þ þ F306I þ þ þ
R7a 7 þ þ F306I þ þ þ þ A204Gw
R7b 7 þ þ F306I þ þ þ
R7c 7 þ þ F306I þ þ þ A120Vw þ
R8 8 þ þ F306I þ þ þ þ þ
R9 9 þ þ F306I þ þ þ þ þ þ
R10 10 þ þ F306I þ þ þ þ þ þ þ
R11a 11 þ þ F306I þ þ þ þ þ þ þ þ
R11b 11 þ þ F306I þ þ þ þ þ þ þ þ
R12 12 þ þ F306I þ þ þ þ þ þ þ þ þ
R13a 13 þ þ F306I þ þ þ þ þ þ þ þ þ þ
R13b 13 þ þ F306I þ þ þ þ þ þ þ þ þ þ
R14 14 þ þ F306I þ þ þ þ þ þ þ þ þ þ þ
R18 18 þ þ F306I þ þ þ þ þ þ þ þ þ þ þ þ þ þ þ
‘þ ’ indicates the mutation is present in the variant.
*Listed are all the mutations that accumulated in the final variant, R18, and their order of appearance in the intermediate variants along the trajectory.
wThese mutations were appeared in the variant in the screening once, however, disappeared later in the round of DNA-shuffling and screening.
Table 3 | The kinetic parameters of variants.
Enzyme Round Paraoxon 2NH
KM (lM) kcat (s 1) kcat/KM (M 1 s 1) KM (lM) kcat (s 1) kcat/KM (M 1 s 1)
R0 0 57±5 1,270±27 2.2 107 179±21 0.075±0.004 4.2 102
R1 1 7±1 62±3 8.9 106 250±32 0.27±0.01 1.1 103
R2a 2 13±3 160±54 1.2 107 220±12 2.9±0.05 1.3 104
R2b 2 18±1 440±10 2.4 107 150±25 24±3 1.6 105
R3 3 21±3 200±58 9.5 106 230±19 3.3±0.1 1.4 104
R4 4 250±17 300±9 1.2 106 120±15 54±2 4.5 105
R5a 5 310±19 60±1 2.2 105 120±14 65±3 5.4 105
R5b 5 67±4 63±1 9.4 105 110±6 54±1 4.9 105
R6 6 80±17 65±2 8.1 105 190±20 130±3 6.8 105
R7a 7 120±2 20±4 1.7 105 160±8 110±2 6.9 105
R7b 7 430±62 53±3 1.2 105 130±11 74±2 5.7 105
R7c 7 180±11 17±1 9.4 104 112±13 28±1 2.3 105
R8 8 300±77 10±1 3.3 104 140±13 73±2 5.2 105
R9 9 320±6 11±1 3.5 104 110±9 350±14 3.2 106
R10 10 240±17 5.7±0.2 2.4 104 190±10 650±17 3.4 106
R11a 11 250±22 4.2±0.1 1.7 104 160±7 340±4 2.1 106
R11b 11 240±20 4.2±0.1 1.8 104 110±12 250±8 2.3 106
R12 12 240±11 6.4±0.1 2.7 104 140±9 400±11 2.9 106
R13a 13 480±9 17±0.1 3.5 104 120±12 420±23 3.5 106
R13b 13 360±39 2.2±0.1 6.1 103 100±10 470±11 4.7 106
R14 14 640±45 0.8±0.1 1.3 103 88±22 490±13 5.6 106
R18 18 1,300±200 0.73±0.1 5.6 102 63±9 880±34 1.4 107
R18-R254H — 4,800±290 0.24±0.2 1.4 102 224±24 0.22±0.04 9.8 102
R18-E233D — 622±17 1.4±0.1 2.2 103 156±10 430±7 2.8 106
R0-D233E — 179±15 580±17 3.2 106 172±17 0.17±0.02 9.8 102
2NH, 2-naphthyl hexanoate.
The means and s.e. of the kinetic parameters were calculated from at least three independent measurements.
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improvements in the newly evolved function, and was incomplete
(R18 exhibited a clear vestige of the original paraoxonase activity;
kcat/KM¼ 560 M 1 s 1).
The molecular basis of diminishing returns and asymmetric
tradeoffs. To investigate the molecular basis of the strong
diminishing returns and asymmetric tradeoffs, a structure of R18
with a bound phosphonate TS analogue of 2NH was solved
(1.65 Å resolution; Supplementary Fig. S1, Supplementary Table
S2 and Supplementary Methods). Although as expected, the
overall architecture of wild-type PTE was retained (RMSD (root-
mean-square deviation)) for R18’s C-a atoms is 0.6 Å), the sub-
strate-binding cavity of R18 was completely reshaped (Fig. 3).
Surprisingly, given the substantial change in this cavity, only 4 of
18 mutations are located within the enzyme’s active site (first
shell), with a further 8 mutations in the active-site periphery
(second shell) and the remaining 6 mutations on the enzyme’s
surface (third shell). Notably, the inner-shell mutations were
accumulated in the first rounds and outer-shell mutations in the
later rounds (Table 2 and Fig. 4a). The chronological order of
accumulation of the mutations from the first to outer shells
relates to the strong diminishing returns of the arylesterase
activity. The effects of the mutations could be classified as follows:
(i) A key leaving group stabilizing substitution: the His254Arg
mutation that was selected in R1 (2.6-fold increase in arylesterase
activity) appears to be the centrepiece around which this
trajectory evolved. In R18, Arg254’s side chain is positioned to
stabilize the negative charge on the napthoxide leaving group
by direct electrostatic interaction, and/or cation–p interactions
(Supplementary Fig. S2). Indeed, reversion of Arg254 to histidine
in the R18 variant resulted in a 4104-fold reduction in the
arylesterase activity, but only a fourfold reduction in the PTE
activity (Table 3). The Brønsted plots for both R18’s and R0’s
arylesterase activity exhibit a slope of near-zero for substrates
with leaving group pKa values Z7.5, indicating that the rate-
limiting step did not change throughout the trajectory
(Supplementary Fig. S3). In the subsequent rounds, second-shell
substitutions had a role in refining the catalytic potential of
Arg254 (see (iii)).
(ii) Substitutions that reshaped the substrate-binding cavity: the
acyl side-chain pocket of R18 was reshaped by the Phe306Leu
substitution in round 2 (increasing the arylesterase activity
by 12-fold) and subsequently the Leu306Ile mutation in round 7.
These changes elongated the cavity. The pocket was then
narrowed by the Leu271Phe mutation in round 13 (Fig. 3). The
reshaping of this active-site pocket is manifested in the acyl
chain length preference changing from 2 to 4 in PTE-R0 to
4–6 in PTE-R18 (Supplementary Fig. S4). Rearrangement of loop
5 also reshaped the active-site cleft: in R18, the tip of loop 5 is
shifted 5.6 Å outwards, relative to wild-type PTE (Fig. 3). It
appears that a number of mutations, including Thr172Ile,
Thr199Ile and Ala204Gly, have stabilized the new loop con-
formation.
(iii) Reinforcing mutations: the molecular basis for the dimin-
ishing returns observed in this trajectory can be explained by a
category of second- and third-shell substitutions that we termed
reinforcing mutations. These substitutions are positioned to sta-
bilize the geometry of the first-shell mutations, particularly
Arg254. When incorporated into wild-type PTE, Arg254 adopts
two rotamers, one of which sterically blocks entrance of the new
substrate into the active site, whereas the other is ideally posi-
tioned to stabilize the developing negative charge on the leaving
group in the TS of the reaction (Fig. 4b). However, only one
Arg254 conformer is observed in the R18 structure, where we
observe that a network of stabilizing interactions has arisen
around the productive, bent, geometry (Fig. 4c). Asp233Glu from
round 2 appears to be the primary reinforcing mutation, only
forming a H-bond with Arg254 in its bent conformation. This is
confirmed by the strong epistatic interaction between these
mutations: the Asp233Glu mutation resulted in a 160-fold
increase in arylesterase activity in the presence of Arg254 (R1),
but only a 2.3-fold increase in the presence of His254 (R0;
Table 3). After Glu233, several other mutations appear to have
added robustness to this geometry, with the backbone carbonyl of
Leu271Phe (round 13) also H-bonding to Arg254 in its bent
form. Several second-shell mutations were located around
Arg254, including Ser269Thr (round 5), Leu272Met (round 9)
and Ile313Phe (round 18). Although the precise roles of these
mutations remain unclear, they are likely to affect the con-
formation of either Arg254 and/or of Ile/Leu306 (Fig. 4). Rein-
forcement is seen in the tolerance of R18 to the Glu233Asp
reversion mutation; when reverted to Asp233 in PTE-R2, a 160-
fold reduction in arylesterase activity is observed, but when the
Phe306
Wild-type PTE Evolved variant R18
Leu271
His254
Asp233
Loop 5
Ile306
Phe271
Arg254
Glu233
Loop 5
Figure 3 | The reshaping of the active-site cavity. Surface views of wild-type PTE’s active site with the paraoxon analogue, diethyl 4-methoxyphenyl
phosphate, and that of the evolved arylesterase R18 in complex with the phosphonate analogue of 2NH’s TS (Protein Data Bank accession code: 4E3T).
The wild-type complex was modelled by superimposing the 490% identical structure of the PTE from Agrobacterium radiobacter complexed with diethyl
4-methoxyphenyl phosphate (Protein Data Bank accession code: 2R1N)23,27 with the structure of PTE (Protein Data Bank accession code: 1DPM). The four
first-shell mutations are depicted as sticks. The position of the C-main chain of loop 5 is shown, and the active-site metals are illustrated as spheres.
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same reversion is performed in PTE-R18 the loss in arylesterase
activity is only fivefold, implying that its stabilizing role has, at
least partially, been reinforced by other mutations that accumu-
lated later in the trajectory.
Several other mutations accumulated around the active site,
and are located on the opposite side of position 254. These
include Met138Ile (round 7), Leu130Val (round 13) and
Leu140Met (round 18). Currently, their roles in switching
PTE’s catalytic activity remain unclear, but the improvements
in 2NHase activity by these mutations are relatively small
(o1.6-fold).
(iv) Compensatory mutations: the third-shell substitutions
mostly appeared during rounds of evolution in which GroEL/ES
overexpression was not applied as well as the neutral drift rounds
(R15–R18). They primarily comprise compensatory, global-sup-
pressor mutations that compensate for the loss of stability asso-
ciated with the first- and second-shell mutations that reshaped
PTE’s active site29,30. These include Ile274Ser (round 3),
Ala80Val (round 10), Ser111Arg, Ala204Gly (round 11),
Ala49Val and Lys77Glu (round 18). These mutations have no
effect on the catalytic specificity (kcat/KM). They do, however,
affect the levels of soluble enzyme in the absence of GroEL/ES
overexpression. For example, round 10 to round 12 were
performed without GroEL overexpression (Table 1). Three
mutations that are distant from the active site (Ala80Val,
Ser111Arg and Ala204Gly) accumulated during these rounds.
The kcat/KM value of the variants carrying these mutations with
2NH remained unchanged (Table 3), yet the enzymatic activity in
crude cell lysates increased. The detailed characterization of these
compensatory mutations will be published elsewhere. Most of
these compensatory substitutions accumulated in the final
rounds, thereby explaining the low return per substitution that
underlined the final stages of this trajectory.
The convex tradeoff function is a result of the bi-functional
nature of the evolutionary intermediates. Best represented by R6,
these intermediates are efficient enzymes for both the original and
the new activities (kcat/KM of B106 M 1 s 1). This bi-
functionality may relate to the conformational plasticity of
these intermediates31, as seen in the coexistence of the two
different conformers of Arg254 described above (Fig. 4). In its
extended conformation, Arg254 is known to aid substrate binding
during the PTE reaction26, but sterically prohibits the arylester
entering the active site. In contrast, in its bent conformation,
Arg254 provides the key electrostatic interaction in the new
arylesterase catalytic mechanism (Supplementary Fig. S5).
Therefore, while the starting and end points of the trajectory
exhibit a single active-site conformation, specialized for a single
reaction, the unstabilized active sites of the intermediates are able
to interconvert between two geometries.
Beside the changes in the shape of active site, metal coordination
changes have been observed. We also solved a structure of R18
with bound cacodylate, an analogue of the phosphodiester product
of paraoxon hydrolysis, (1.50 Å resolution), and a structure of R18
in the absence of any ligand (1.85 Å). The binuclear metal ion
centre of PTE at the active site (a- and b-sites) catalyses hydrolysis
by stabilizing both the hydroxide nucleophile and the developing
negative charge on the TS23,28,32,33. The metal ion centre also
involves the carboxylation of a lysine residue34. Both metal ions are
seen in the available PTE structures, including engineered
mutants35,36. However, the ligand-free structure of R18 was
found to have a barely occupied b-site, a partially filled a-site
and a previously unseen observed g-site (Supplementary Fig. S6
and Supplementary Fig. S7). Metal-ion reconstitution experiments
indicated that complete reactivation of apo-R18 is achieved at 2:1
Zn2þ :enzyme stoichiometry (Supplementary Fig. S8). This
suggests that the original binuclear state remains the catalytically
relevant form. Indeed, the binuclear centre is seen in the structures
of R18 with bound TS analogue and cacodylate: the occupancy of
Zn2þ at the b-site is significantly higher in these structures, and at
a comparable level to the occupancy of the ligand. In other words,
the same binuclear active-site functions in R18 as in PTE, but in
R18 it seems to be dependent on substrate binding (Supplementary
Fig. S7). Indeed, R18 loses activity much more rapidly than R0 in
metal-ion-free buffer (Supplementary Fig. S9). The evolution of
PTE into R18 has therefore resulted in the metal-ion-binding
affinity being significantly weakened, and in the emergence of the
g-site, the role of which in the arylesterase activity remains to be
understood.
H254R 
I274S 
D233E
F306L/I
S269T 
T172I
M138I
T199I 
S111R
A80V
A204G 
L271F
L272M 
L130V
L140M
K77E 
A49V 
I313F 
a R1
R2
R3–R6
R7–R9
R10–R12
R13–R14
R15 –R18
b
c
IIe313
IIe306
Leu272
Leu271
Phe306
Phe313
Phe271
Met272
Glu233
Asp233
Arg254
Arg254
Figure 4 | The molecular basis of diminishing returns. (a) Backbone diagram of the evolved arylesterase (PTE-R18) with the bound 2NH TS analogue (as
sticks). The substitutions underlying R18’s divergence are depicted as spheres. The colour scheme corresponding to their order of appearance is red (early),
orange (intermediate) to green (late). (b) The active site of wild-type PTE-Arg254 with diethyl 4-methoxyphenyl phosphate (in magenta sticks; Protein
Data Bank accession code: 1QW7). Note the two rotamers of Arg25428. (c) The active site of the evolved arylesterase with the 2NH TS analogue (in
magenta sticks). Arg254 adopts a single rotamer.
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Discussion
The complete transition in enzyme activity, a 109-fold shift in the
PTE/arylesterase catalytic specificities, sheds light on the
molecular basis of the diminishing returns and asymmetric
tradeoffs that underlined this functional switch. Although we do
not exclude the possibility of alternative trajectories that lead to
the same outcome (arylesterase), which may exhibit different
dynamics, we surmise that these features are general. As dimini-
shing returns are observed in various biological systems5–9,
this phenomenon would be an inherent property of all
optimization/evolutionary processes. Either in nature or in the
laboratory, evolution selects variants from the population that
best meet the selection criteria. Naturally, few mutational
solutions are available that give large improvements, and these
seem to be exhausted within the first few generations.
The diminishing returns seem to relate to the fact that over the
18 rounds, the mutations appear to radiate outwards from the
first mutations within the active site, to the later mutations
stabilizing the enzyme or reinforcing the effects of the early ones.
Only 4 out of 18 mutations were located in the first shell of the
active site and directly contact the substrates, and 3 out of these
4 mutations appeared in the first two rounds of evolution. The
structural analysis indicates the later mutations reinforce the
effects of the early ones. The proposed reinforcement model
explains the frequent observation from directed evolution
experiments that second- and third-shell mutations improve
enzyme and protein functions10,21,37–39. Compensatory
mutations that alleviate the stability losses imposed by the
active-site mutations also belong to this category29,30,40,41. They
appeared at positions distant from the active site (third shell,
primarily) and provide further support for the role of distant
mutations in the evolution of new protein functions.
The strong diminishing returns and asymmetric tradeoff
observed in the evolutionary optimization of our laboratory-
evolved arylesterase illustrate how difficult it is to achieve full
optimization of a trait such as catalytic specificity and provide a
molecular explanation for the sub-optimal kinetic parameters and
broad specificity observed in many naturally evolved enzymes.
Our in vitro evolution protocol yielded one mutation per gene per
generation, and the most active variant from every round was
selected. It thereby resulted in the complete fixation of mutations
in the selected variants, regardless of the level of improvement
these mutations provided. In other words, mutations were fixed at
a constant pace of one per generation (round), so long as they
provided a selective advantage, but irrespective of their fitness
gain (selection coefficient) and population size. In nature, the
selection pressures acting to refine enzyme activity are far more
complex. Foremost, the likelihood of fixation of a mutation is
proportional to its fitness gain and also depends on population
size. Mutations that provide relatively small gains, as observed
here from round 5 thereafter, may require many generations to
fixate, or may never fixate, particularly within small popula-
tions42,43. Thus, the final refinement stages of enzymes whose
contribution to overall organismal fitness is small and/or
transitory can be extremely slow, or may never occur. Indeed, a
recent bioinformatics study showed the average kcat/KM value of
enzymes in secondary metabolism (7 104 M 1 s 1) is ca. an
order of magnitude lower than enzymes in primary metabolism,
and the average kcat value is 430-fold lower44. Overall, enzymes
in secondary and specialized metabolism seem multifunctional
and poorly specialized, in accordance with their weak and
transient contribution to survival and growth rates45.
Similarly, the asymmetric tradeoff that results in high-catalytic
specificity for the arylesterase function only appears after round
14 (at which point the arylesterase becomes Z1,000-fold higher
than PTE activity). A growing body of evidence suggests that
many enzymes exhibit broad catalytic specificity and/or promis-
cuity11,17, particularly enzymes in secondary metabolism44–48.
Broad specificity may therefore relate to the recent divergence of
secondary and specialized metabolism enzymes relative to
primary metabolic enzymes, as well as the intensity of selection
being weaker than it is for enzymes in primary metabolism45,49.
For example, 37% of E. coli’s enzymes catalyse more than one
reaction in vivo, and they catalyse 65% of E. coli metabolic
reactions49. The specialization appears to be related to the
metabolic context—essential transformations that proceed with
high flux and require more regulation49. It is therefore likely that
many proteins, and in particular enzymes of specialized metabolic
pathways, are far from their functional optimum and could be
readily improved by means of laboratory evolution50.
Methods
Materials. 2NH and paraoxon were purchased from Sigma. The TS analogue of
2NH hexylphosphonate 2-naphthyl ester was synthesized based on previously
published procedures51. Briefly, the di-2-naphthyl ester was synthesized by reacting
hexylphosphonic dichloridate with 2-naphthol in dichloromethane using
triethylamine as base. The reaction mixture was extracted with bicarbonate, diluted
hydrochloric acid and brine. The solvent was evaporated, and the crude diester
product was dissolved in acetonitrile and hydrolysed by addition of two equivalents
of sodium hydroxide (2.5 h at room temperature). The solvent was evaporated, and
the residual solid was dissolved in water. The released 2-naphthol was extracted
into dichloromethane by mild acidification, followed by addition of 5 N HCl to
extract the phosponate monoester product. The solvent was removed and the
product was dissolved in water plus ammonium hydroxide. The solution was
lyophilized and the resulting ammonium salt was purified by recrystallization from
acetonitrile-ether-hexane.
Cloning and library construction. PTE genes were cloned with Nco I and Hind III
sites into pET-strep26 vector to express the strep-tag–PTE fusion protein for the
evolution experiment and purification for the enzyme kinetics and stability assay.
For crystallization, PTE-R18 was cloned into a modified pET32-trx vector and
expressed without the tag. The modified expression vectors pET-T72, which carried
two mutations in T7 promoter region (A-6T and A-16C), and pET-T74, which
carried four mutations (A-6T, T-8A, A-10T and A-16C), were created by site
directed mutagenesis. PTE libraries were generated by random mutagenesis with
error-prone PCR using the ‘wobble’ base analogues dPTP and 8-oxo-dGTP
(TriLink) and the DNA shuffling method. The first 20 PCR cycles with primers
flanking the cloned genes were performed with Taq polymerase (Bioline) in 50 ml
reactions using 1 ng of plasmid template, with 1 mM dPTP, 20mM 8-oxo-dGTP and
0.25 mM of each of the four standard dNTPs. The PCR products were treated with
Dpn I to digest the template plasmid, purified and then used as a template (20 ng
per 50 ml reaction) for another 20 PCR cycles with nesting primers and Bio Taq
polymerase (Bioline). The product of this final PCR was purified, digested with
restriction enzymes NcoI and HindIII (NEB, 3 h at 37 1C) and ligated into one of
the modified pET vectors as described above. This protocol created libraries
carrying an average two to three nucleotide substitutions per gene with high
reproducibility.
Directed evolution. Gene libraries were transformed into E. coli BL21 (DE3) cells
carrying the pGro7 plasmids encoding the GroEL/ES chaperonin. Transformed
cells were plated on LB agar plates with amp (100 mg ml 1 ampicillin), cam
(34 mg ml 1 chloramphenicol) and 0.2% glucose and incubated overnight. The
colonies were replicated using a velvet cloth to LB agar–amp–cam containing
100 mM ZnCl2, 1 mM isopropyl-b-D-thiogalactoside and 0.2% arabinose (for
overexpression of GroEL/ES) or 0.2% glucose (suppression of GroEL/ES). Subse-
quently, top agar (0.5% agar in 100 mM Tris–HCl pH 7.5) containing 50 mM 2NH
and 200 mM FAST Red (Sigma) was layered. About 3,000–5,000 colonies were
screened using FAST Red in each round. Subsequently, B540 colonies (six 96-well
plates) showing the fastest development of red colour were picked from the replica
plates, grown in 96-well plates and assayed for 2NH hydrolysis. Thirty variants that
showed the highest 2NH hydrolase activity were picked and streaked onto LB agar–
amp–cam. Three individual colonies from each variant were picked and their
activities with 2NH were retested. Variants that showed Z1.3-fold higher 2NH
activity than the starting point (the best variant from the previous round) were
recognized as positives. Paraoxon hydrolysis for variants was also recorded but was
not taken into consideration for choosing the templates for the next round. The
experimental conditions such as the mutagenesis protocol and the selection con-
ditions (overexpression of GroEL/ES, growth temperature, promoter strength and
so on) were varied in each round to maintain the screen’s dynamic range such that
improved variants could be identified. When multiple variants were identified as
positives, gene shuffling (homologous recombination in vitro) was used to create
the next-generation library.
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Enzyme purification. To determine kinetic parameters, the PTE variants were
purified using strep-tactin affinity columns (IBA) using the manufacturer’s pro-
tocol. The buffer of the eluted proteins was exchanged with 100 mM Tris-HCl pH
7.5, and the samples were concentrated, using Vivaspin centrifugal ultrafiltration
(Satorius Stedim Biotech). For crystallization, PTE-R18 was expressed without
the strep-tag, and purified by DEAE sepharose ion-exchange chromatography
(GE Healthcare) followed by SP sepharose ion-exchange chromatography
(GE Healthcare) and Superdex 200 size-exclusion chromatography (GE
Healthcare).
Enzyme kinetics. Initial velocities (v0) were determined at 12 different substrate
concentrations (2–2,000 mM) in 100 mM Tris-HCl pH 7.5, 100 mM ZnCl2 and
0.02% Triton X-100. Hydrolysis rates were monitored using a microplate reader by
following product formation at 500 nm for 2NH (in the presence of 2 mM FAST
Red) and at 405 nm for paraoxon. KM and kcat were determined by fitting the initial
rates of the Michaelis–Menten model (v0¼ kcat[E]0[S]0/(KMþ [S]0)) using Kalei-
daGraph (Synergy Software). The rates of enzymatic hydrolyses of the different
phenol esters were determined with 4-nitrophenyl acetate (pKa of the phenol
leaving group¼ 7.14), 4-acetoxy benzaldehyde (7.66), 4-cyanophenyl acetate (7.95),
4-acetoxy acetophenone (8.05), 3-nitrophenyl acetate (8.39), 4-acetoxy methyl
benzoate (8.47), 3-cyanophenyl acetate (8.61), 3-fluorophenyl acetate (9.28), phenyl
acetate (10), 4-methyl phenyl acetate (10.2), 4-methoxy phenyl acetate (10.29) and
3,4 dimethyl phenyl acetate (10.34). Detailed information about these substrates
and assay wavelengths is provided in Vanhooke et al.27
Zinc ion titration. PTE variants (20 mM) in 20 mM HEPES (pH 7.5) were incu-
bated for 24 h at 4 1C in a solution with 5 mM of EDTA and 5 mM 1,10-phe-
nanthroline. The chelators were removed by passing the mixture through an
Econo-Pac 10DG gel filtration column (10 ml column volume, Bio-Rad) that was
equilibrated by sequential passages of Chelex-treated 50 mM HEPES (pH 8.5). The
resulting metal-free, apoenzyme (as indicated by complete loss of activity, 1 mM,)
was incubated with freshly prepared solutions of ZnCl2 at various concentrations
(0.1–20 mM) in 50 mM HEPES pH 8.0 for 48 h at room temperature. The enzyme
solution was diluted and the recovered catalytic activity was measured with 2NH
(200 mM) and paraoxon (200 mM).
Zinc ion dissociation. The apoenzymes (20 mM) were reconstituted with freshly
prepared 1 mM of ZnCl2 and incubated for 48 h at 4 1C. And an excess of Zn2þ
ions was removed by passing the mixture through an Econo-Pac 10DG (Bio-Rad)
gel filtration column that was equilibrated with Chelex-treated 50 mM HEPES (pH
7.5). The enzyme was diluted to 1 mM and dialysed into 50 mM HEPES, 100 mM
NaCl (pH 6.5). The samples were taken from the dialysis bag, diluted, and the
enzymatic activities of paraoxon and 2NH were measured every hour.
Crystallization. For crystallization, PTE-R18 was purified via cation exchange
chromatography (Resource S column, 50 mM MES pH 6.0) and gel filtration
(25 mM HEPES pH 8.0, 50 mM NaCl). Crystals were grown at pH 6.5 (50 mM
MES) using 30% MPD and 2% PEG 8K as precipitants. Crystals of R18 in complex
with cacodylate were grown in identical conditions, with the exception that 50 mM
Na-Cacodylate was used as a buffer instead of MES. The concentration of MPD
was increased to 40% for the use as a cryoprotectant during flash cooling of the
crystals under a stream of nitrogen gas (100 K). For crystal soaking experiments,
10 mM hexylphosphonate 2-naphthyl ester was included in the cryobuffer and
crystals were soaked for 10 min. Diffraction data were collected from beamline
14–4 at the European Synchrotron Radiation Facility at a wavelength of 0.9793 Å,
or beamline 23–2 at a wavelength of 0.8726 Å. Data were integrated using the XDS
package52 and scaled using the program SCALA53. Data collection statistics are
shown in Supplementary Table S2. Difference Fourier maps were used to confirm
the mutations identified by sequencing of R18 and the presence of the ligands,
hexylphosphonate 2-naphthyl ester and cacodylate. The mutated residues and the
ligand were altered accordingly in our models, and solvent and other
conformational differences from the starting model were remodelled using Coot54.
Refinement was performed with phenix.refine55. Five percent of the reflections
were omitted from the refinement for the purpose of cross-validation. Analysis of
the structure of the H254R mutant of PTE was performed using deposited structure
factors and coordinates obtained from the Protein Data Bank (accession code:
1QW7)56.
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